Xtl Biopharmaceuticals (XTLB) Receivables - Other (2009 - 2019)
Xtl Biopharmaceuticals (XTLB) posted Receivables - Other of $7,000 for the quarter ended Dec 31, 2019, down 36.4% from $11,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Receivables - Other (2009 - 2019) Analysis & Trends
Since the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals has reported Receivables - Other for 32 quarters.
- Annual Receivables - Other has declined for three consecutive years, with a five-year compound annual growth rate of -56.3% (years ended Dec 2014 to Dec 2019).
- In prior years, Xtl Biopharmaceuticals' Receivables - Other was $11,000 in the year ended Dec 31, 2018 (-90.2%), $112,000 in the year ended Dec 31, 2017 (-65.1%), $321,000 in the year ended Dec 31, 2016 (+62.9%) and $197,000 in the year ended Dec 31, 2015 (-54.9%).
- The figure for the quarter ended Dec 31, 2019 stands as the lowest quarterly Receivables - Other in data going back to the quarter ended Mar 31, 2009.
- The strongest year-over-year quarter for Receivables - Other in the past five years was the quarter ended Jun 30, 2016, with growth of 101.6%; the weakest was the quarter ended Dec 31, 2016, with a decline of 93.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 7,000.00 |
| Dec 31, 2018 | 11,000.00 |
| Dec 31, 2017 | 12,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Jun 30, 2016 | 250,000.00 |
| Dec 31, 2015 | 197,000.00 |
| Sep 30, 2015 | 231,000.00 |
| Jun 30, 2015 | 124,000.00 |
| Dec 31, 2014 | 437,000.00 |
| Sep 30, 2014 | 616,000.00 |
| Jun 30, 2014 | 531,000.00 |
| Mar 31, 2014 | 573,000.00 |
| Dec 31, 2013 | 473,000.00 |
| Sep 30, 2013 | 867,000.00 |
| Jun 30, 2013 | 168,000.00 |
| Mar 31, 2013 | 166,000.00 |
| Sep 30, 2012 | 128,000.00 |
| Jun 30, 2012 | 109,000.00 |
| Mar 31, 2012 | 90,000.00 |
| Sep 30, 2011 | 49,000.00 |
API Access
Xtl Biopharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();